Sign in
4

Changes in Ownership

Edwards Lifesciences Corp Filed Acc 0001225208-25-003194

CVP, JAPAC sold 400 shares at $69.48 ($27,792)

  • CVP, JAPAC acquired 400 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Lippis Daniel J. · CVP, JAPAC

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-03-10 Exercise or conversion : show line 1 in the form 10b5-1 +400 $45.28 $18,111 22,988.07 D
2025-03-10 Sale : show line 2 in the form 10b5-1 −400 $69.48 $27,792 22,588.07 D
Open-market sales · 400 sh · avg $69.48 · $27,792

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-03-10 Exercise or conversion : show line 3 in the form 10b5-1 Employee Stock Option (Right to Acquire) −400 630 D
Loading xslF345X05/doc4.xml…